Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2005 2
2006 1
2007 2
2008 1
2009 4
2010 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
Picaud JC, Pajek B, Arciszewska M, Tarczón I, Escribano J, Porcel R, Adelt T, Hassink E, Rijnierse A, Abrahamse-Berkeveld M, Korczowski B, On Behalf Of The Tenuto Study Group. Picaud JC, et al. Among authors: hassink e. Nutrients. 2020 Jul 13;12(7):2072. doi: 10.3390/nu12072072. Nutrients. 2020. PMID: 32668666 Free PMC article. Clinical Trial.
Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.
van Vonderen MG, Blümer RM, Hassink EA, Sutinen J, Ackermans MT, van Agtmael MA, Yki-Jarvinen H, Danner SA, Serlie MJ, Sauerwein HP, Reiss P. van Vonderen MG, et al. Among authors: hassink ea. J Acquir Immune Defic Syndr. 2010 Feb;53(2):186-93. doi: 10.1097/QAI.0b013e3181c190f4. J Acquir Immune Defic Syndr. 2010. PMID: 19898246 Clinical Trial.
Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.
Franssen R, Sankatsing RR, Hassink E, Hutten B, Ackermans MT, Brinkman K, Oesterholt R, Arenas-Pinto A, Storfer SP, Kastelein JJ, Sauerwein HP, Reiss P, Stroes ES. Franssen R, et al. Among authors: hassink e. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1336-41. doi: 10.1161/ATVBAHA.109.192088. Epub 2009 Aug 10. Arterioscler Thromb Vasc Biol. 2009. PMID: 19667106 Clinical Trial.
Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
van Vonderen MG, van Agtmael MA, Hassink EA, Milinkovic A, Brinkman K, Geerlings SE, Ristola M, van Eeden A, Danner SA, Reiss P; MEDICLAS study group. van Vonderen MG, et al. Among authors: hassink ea. PLoS One. 2009 May 21;4(5):e5647. doi: 10.1371/journal.pone.0005647. PLoS One. 2009. PMID: 19479079 Free PMC article. Clinical Trial.
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
Boyd MA, Srasuebkul P, Khongphattanayothin M, Ruxrungtham K, Hassink EA, Duncombe CJ, Ubolyam S, Burger DM, Reiss P, Stek M Jr, Lange J, Cooper DA, Phanuphak P. Boyd MA, et al. Among authors: hassink ea. Antivir Ther. 2006;11(2):223-32. Antivir Ther. 2006. PMID: 16640103 Clinical Trial.
15 results